Literature DB >> 9240434

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

K Horie1, T Miyata, T Yasuda, A Takeda, Y Yasuda, K Maeda, G Sobue, K Kurokawa.   

Abstract

Lipofuscins are intracellular fluorescent pigments accumulating in the central nervous system (CNS) with aging and degenerative processes such as Alzheimer's disease (AD). Although they are thought to be lipid peroxidation products derived from malondialdehyde, their biogenesis remains controversial. We further characterize the chemical nature of lipofuscins in brain tissues from AD patients and normal aged subjects. Advanced glycation end products (AGEs), pentosidine and carboxymethyllysine (CML), were identified by appropriate specific antibodies. They have physicochemical properties similar to those of lipofuscin and also increase with aging. Pentosidine and CML were identified in the neuronal perikarya and the extraneuroperikaryal deposits of both the AD and aged brain. Pentosidine, but not CML, was present in the fiber-like structure within the neuropil and the core of classical senile plaque. In the brain of young subjects without CNS disease, pentosidine and CML staining was faint. Pentosidine and CML co-localized with lipofuscin pigments in the neuronal perikarya of both the AD and aged brain. We demonstrate for the first time that lipofuscin is constituted not only of lipid peroxidation products but also from glycation products which may be the origin of fluorescent pigments. Lipofuscins should thus be considered as fluorescent pigments generated by lipid- and sugar-derived Schiff base-protein polymers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240434     DOI: 10.1006/bbrc.1997.6944

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

Review 2.  Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.

Authors:  T Cukierman; H C Gerstein; J D Williamson
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

Review 3.  AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2019-05-11       Impact factor: 3.396

4.  Advanced glycation end product level, diabetes, and accelerated cognitive aging.

Authors:  Kristine Yaffe; K Lindquist; A V Schwartz; C Vitartas; E Vittinghoff; S Satterfield; E M Simonsick; L Launer; C Rosano; J A Cauley; T Harris
Journal:  Neurology       Date:  2011-09-07       Impact factor: 9.910

5.  Hepatic disposal of advanced glycation end products during maturation and aging.

Authors:  Dmitri Svistounov; Ana Oteiza; Svetlana N Zykova; Karen Kristine Sørensen; Peter McCourt; Andrew J McLachlan; Robert S McCuskey; Bård Smedsrød
Journal:  Exp Gerontol       Date:  2013-03-24       Impact factor: 4.032

6.  D-Ribosylated Tau forms globular aggregates with high cytotoxicity.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  Cell Mol Life Sci       Date:  2009-06-11       Impact factor: 9.261

7.  Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain.

Authors:  Nopporn Thangthaeng; Nathalie Sumien; Michael J Forster
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

8.  Inhibition of crystallin ascorbylation by nucleophilic compounds in the hSVCT2 mouse model of lenticular aging.

Authors:  Xingjun Fan; Vincent M Monnier
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-17       Impact factor: 4.799

9.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

Review 10.  Aging is not a disease: distinguishing age-related macular degeneration from aging.

Authors:  Daniel Ardeljan; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2013-08-09       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.